You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 3, 2024

Claims for Patent: 10,350,214


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,350,214
Title:Preparation containing tetracyclic compound at high dose
Abstract: An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihy- dro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
Inventor(s): Tomimatsu; Takashi (Tokyo, JP), Okazaki; Kensuke (Tokyo, JP), Ogawa; Yumi (Tokyo, JP), Yamamura; Takahiro (Tokyo, JP)
Assignee: CHUGAI SEIYAKU KABUSHIKI KAISHA (Tokyo, JP)
Application Number:15/304,133
Patent Claims: 1. A pharmaceutical formulation comprising (i) a granule containing a compound represented by formula (I) ##STR00004## or a salt thereof and (ii) carmellose calcium as a disintegrating agent, wherein the compound represented by formula (I) or a salt thereof is contained in an amount of 140 mg to 190 mg in terms of the free form per unit formulation.

2. The formulation according to claim 1, wherein the carmellose calcium (ii) is contained in an amount of 5 wt % or more based on the total amount of the formulation.

3. The formulation according to claim 1, wherein the carmellose calcium (ii) is contained in an amount of 7.5 wt % or more based on the total amount of the formulation.

4. The formulation according to claim 1, wherein the granule contains carmellose calcium therein.

5. The formulation according to claim 1, wherein the granule contains a solubilizing agent therein.

6. The formulation according to claim 5, wherein the solubilizing agent is sodium lauryl sulfate.

7. The formulation according to claim 6, wherein sodium lauryl sulfate is obtained by crystallization.

8. The formulation according to claim 5, wherein the weight ratio of the compound represented by formula (I) to the solubilizing agent is 100:2 to 100:60.

9. The formulation according to claim 8, wherein the compound represented by formula (I) or a salt thereof is contained in an amount of 35 to 60 wt % based on the total amount of the formulation.

10. The formulation according to claim 1, wherein the granule contains a binder therein.

11. The formulation according to claim 10, wherein the binder is hydroxypropylcellulose.

12. The formulation according to claim 1, wherein the granule has a mean particle diameter of 150 .mu.m or more.

13. The formulation according to claim 1, wherein the granule has a mean particle diameter of 200 .mu.m or more.

14. The formulation according to claim 1, wherein a compound represented by formula (I) or a salt thereof is contained in an amount of 20 to 70 wt % in terms of the free form based on the total amount of the formulation.

15. A method for producing a formulation improved in solubility of a compound represented by formula (I) ##STR00005## or a salt thereof, comprising (i) granulating a granule containing a compound represented by formula (I) or a salt thereof and (ii) blending carmellose calcium as a disintegrating agent and optionally other additives as external additives, wherein the compound represented by formula (I) or a salt thereof is contained in an amount of 140 mg to 190 mg in terms of the free form per unit formulation.

16. The method according to claim 15, wherein the carmellose calcium (ii) is contained in an amount of 7.5 wt % or more and 30 wt % or less based on the total amount of the formulation.

17. The method according to claim 15, wherein the granule has a mean particle diameter of 150 .mu.m or more and 1 mm or less.

18. The method according to claim 15, wherein the granule has a mean particle diameter of 180 .mu.m or more and 1 mm or less.

19. The method according to claim 15, wherein the granule (i) has carmellose calcium therein.

20. The method according to claim 15, wherein the granule contains a solubilizing agent therein.

21. The method according to claim 20, wherein the solubilizing agent is sodium lauryl sulfate obtained by crystallization.

22. The method according to claim 20, wherein a weight ratio of the compound represented by formula (I) to the solubilizing agent is 100:2 to 100:60.

23. The method according to claim 15, wherein the granule contains a binder therein.

24. The method according to claim 23, wherein the binder is hydroxypropylcellulose.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.